Surgical treatment for esophageal cancer: Current issues

Digestive Surgery

Volumn 24, Issue 2, 2007, Pages 88-95

  Kato, Hiroyuki ^a   Fukuchi, Minoru ^a   Miyazaki, Tatsuya ^a   Nakajima, Masanobu ^a   Tanaka, Naritaka ^a   Inose, Takanori ^a   Kimura, Hitoshi ^a   Faried, Ahmad ^a   Saito, Kana ^a   Sohda, Makoto ^a   Fukai, Yasuyuki ^a   Masuda, Norihiro ^a   Manda, Ryokuhei ^a   Ojima, Hitoshi ^a   Tsukada, Katsuhiko ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Esophageal cancer; Minimally invasive surgery; Neoadjuvant therapy; Salvage treatment

Indexed keywords

CISPLATIN; FLUOROURACIL;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; HYPERTHERMIC THERAPY; INTERMETHOD COMPARISON; LAPAROTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MINIMALLY INVASIVE SURGERY; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PROGNOSIS; RADIATION DOSE; REVIEW; SALVAGE THERAPY; SKIN INCISION; SURGICAL APPROACH; SURVIVAL RATE; SURVIVAL TIME; THORACOTOMY; THORAX SURGERY; TREATMENT OUTCOME; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS;

EID: 34249052900     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101894     Document Type: Review

References (87)

1. Law S, Wong J: Current management of esophageal cancer. J Gastrointest Surg 2005; 9:291-310.
2. Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053.
3. Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Nakajima M, Fukai Y, Sohda M, Kimura H, Faried A: Genetic alterations in esophageal cancer. Surg Today 2005;35:7-18.
4. Wright CD: Esophageal cancer surgery in 2005. Minerva Chir 2005;60:431-444.
5. Enzinger PC, Mayer RJ: Esophageal cancer. N Engl J Med 2003;349:2241-2252.
6. Pommier RF, Vetto JT, Ferris BL, Wilmarth TJ: Relationships between operative approaches and outcomes in esophageal cancer. Am J Surg 1998;175:422-425.
7. Rentz J, Bull D, Harpole D, et al: Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg 2003;125:1114-1120.
8. Hulscher JBF, Tijssen JGP, Obertop H, van Lanschot JJB: Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001;72: 306-313.
9. Hagen JA, Peters JH, DeMeester TR: Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993; 106:850-858.
10. Goldminc M, Maddern G, Le Prise E, Meunier B, Campion JP, Launois B: Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg 1993;80:367-370.
11. Chu KM, Law SY, Fok M, Wong J: A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 1997;174: 320-324.
12. Hulscher JBF, van Sandick JW, Boer AGEM, et al: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-1669.
13. Kato H, Watanabe H, Tachimori Y, Iizuka T: Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 1991;51:931-935.
14. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-373.
15. Isono K, Sato H, Nakayama K: Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991;48:411-420.
16. Fujita H, Kakegawa T, Yamana H, et al: Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Ann Surg 1995;222:654-662.
17. Baba M, Aikou T, Yoshinaka H, et al: Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994; 219:310-316.
18. Matsubara T, Ueda M, Nagao N, Takahashi T, Nakajima T, Nishi M: Cervicothoracic approach for total mesoesophageal dissection in cancer of the thoracic esophagus. J Am Coll Surg 1998;187:238-245.
19. Nishimaki T, Suzuki T, Suzuki S, Kuwabara S, Hatakeyama K: Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 1998;186:306-312.
20. Nishihira T, Hirayama K, Mori S: A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998;175:47-51.
21. Watanabe H, Kato H, Tachimori Y: Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan. Recent Results Cancer Res 2000;155: 123-133.
22. Tabira Y, Kitamura N, Yoshioka M, Tanaka M, Nakano K, Toyota N, Mori T: Significance of three-field lymphadenectomy for carcinoma of the thoracic esophagus based on depth of tumor infiltration, lymph nodal involvement and survival rate. J Cardiovasc Surg (Torino) 1999;40:737-740.
23. Shiozaki H, Yano M, Tsujinaka T, Inoue M, Tamura S, Doki Y, Yasuda T, Fujiwara Y, Monden M: Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus 2001;14: 191-196.
24. Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Ectors N: Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004;240:962-972.
25. Altorki N, Kent M, Ferrara C, Port J: Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-183.
26. Udagawa H, Akiyama H: Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique. Dis Esophagus 2001;14:110-114.
27. Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, Shimizu T, Shuto K, Hayashi H, Ochiai T: Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg 2006;30:1441-1449.
28. Fujita H, Sueyoshi S, Tanaka T, Fujii T, Toh U, Mine T, Sasahara H, Sudo T, Matono S, Yamana H, Shirouzu K: Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy. World J Surg 2003;27:571-579.
29. Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N: Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005;189:98-109.
30. Cuschieri A, Shimi S, Banting S: Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 1992; 37:7-11.
31. Azagra JS, Ceuterick M, Goergen M, et al: Thoracoscopy in oesophagectomy for oesophageal cancer. Br J Surg 1993;80:320-321.
32. Gossot D, Fourquier P, Celerier M: Thoracoscopic esophagectomy: technique and initial results. Ann Thorac Surg 1993;56:667-670.
33. Collard JM, Lengele B, Otte JB, Kestens PJ: En bloc and standard esophagectomies by thoracoscopy. Ann Thorac Surg 1993;56: 675-679.
34. McAnena OJ, Rogers J, Williams NS: Right thoracoscopically assisted oesophagectomy for cancer. Br J Surg 1994;81:236-238.
35. Dexter SP, Martin IG, McMahon MJ: Radical thoracoscopic esophagectomy for cancer. Surg Endosc 1996;10:1113-1115.
36. Robertson GS, Lloyd DM, Wicks AC, Veitch PS: No obvious advantages for thoracoscopic two-stage oesophagectomy. Br J Surg 1996; 83:675-678.
37. Law S, Fok M, Chu KM, Wong J: Thoracoscopic esophagectomy for esophageal cancer. Surgery 1997;122:8-14.
38. Akaishi T, Kaneda I, Higuchi N, et al: Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy. J Thorac Cardiovasc Surg 1996;112:1533-1540.
39. Kawahara K, Maekawa T, Okabayashi K, et al: Video-assisted thoracoscopic esophagectomy for esophageal cancer. Surg Endosc 1999;13:218-223.
40. Osugi H, Takemura M, Higashino M, Takada N, Lee S, Kinoshita H: A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 2003;90:108-113.
41. Osugi H, Takemura M, Higashino M, et al: Learning curve of video-assisted thoracoscopic esophagectomy and extensive lymphadenectomy for squamous cell cancer of the thoracic esophagus and results. Surg Endosc 2003;17:515-519.
42. Taguchi S, Osugi H, Higashino M, et al: Comparison of three-field esophagectomy for esophageal cancer incorporating open or thoracoscopic thoracotomy. Surg Endosc 2003;17:1445-1450.
43. Smithers BM, Gotley DC, McEwan D, Martin I, Bessell J, Doyle L: Thoracoscopic mobilization of the esophagus. A 6 year experience. Surg Endosc 2001;15:176-182.
44. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al: Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003;238:486-494.
45. Nguyen NT, Roberts P, Follette DM, Rivers R, Wolfe BM: Thoracoscopic and laparoscopic esophagectomy for benign and malignant disease: lessons learned from 46 consecutive procedures. J Am Coll Surg 2003; 197:902-913.
46. Horgan S, Berger RA, Elli EF, Espat NJ: Robotic-assisted minimally invasive transhiatal esophagectomy. Am Surg 2003;69:624-626.
47. Bodner JC, Zitt M, Ott H, et al: Robotic-assisted thoracoscopic surgery (RATS) for benign and malignant esophageal tumors. Ann Thorac Surg 2005;80: 1202-1206.
48. Pierre AF, Luketich JD: Technique and role of minimally invasive esophagectomy for premalignant and malignant diseases of the esophagus. Surg Oncol Clin North Am 2002; 11:337-350.
49. Cuesta MA, van den Broek WT, van der Peet DL, Meijer S: Minimally invasive esophageal resection. Semin Laparosc Surg 2004;11: 147-160.
50. Malthaner RA, Wong RK, Rumble RB, Zuraw L: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med 2004;2:35.
51. Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS: Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a metaanalysis of randomized clinical trials. Ann Surg Oncol 2003;10:754-761.
52. Urschel JD, Vasan H, Blewett CJ: A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2002;183:274-279.
53. Sugimachi K, Kitamura K, Baba K, Ikebe M, Morita M, Matsuda H, Kuwano H: Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus - a prospective randomized trial. Int J Hyperthermia 1992;8:289-295.
54. Fiorica F, Di Bona D, Schepis F, Licata A, Shahied L, Venturi A, Falchi AM, Craxi A, Camma C: Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004;53:925-930.
55. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538-543.
56. Greer SE, Goodney PP, Sutton JE, Birkmeyer JD: Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 2005;137:172-177.
57. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-313.
58. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier JC, Pavy JJ, Mercier M, Sahmoud T: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167.
59. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, Boutin D, Campion JP, Launois B: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-1784.
60. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994;41: 391-393.
61. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, Mantyla M, Modig H, Munck-Wikland E, Rosengren B, et al: Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-1110.
62. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335:462-467.
63. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET, Denham JW: Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005;6:659-668.
64. Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, Makuuchi H, Tanaka O, Yamana H, Ikeuchi S, Kabuto T, Nagai K, Shimada Y, Kinjo Y, Fukuda H: Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study - JCOG9204. J Clin Oncol 2003;21:4592-4596.
65. Teniere P, Hay JM, Fingerhut A, Fagniez PL: Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 1991;173:123-130.
66. Fok M, Sham JS, Choy D, Cheng SW, Wong J: Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993;113:138-147.
67. Zieren HU, Muller JM, Jacobi CA, Pichlmaier H, Muller RP, Staar S: Adjuvant post-operative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 1995;19:444-449.
68. Xiao ZF, Yang ZY, Liang J, Miao YJ, Wang M, Yin WB, Gu XZ, Zhang de C, Zhang RG, Wang LJ: Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003;75: 331-336.
69. Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A: Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any)M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003;57:425-433.
70. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL: Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-1627.
71. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Daivis L, Emami B: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326:1593-1598.
72. Geh JI, Crellin AM, Glynne-Jones R: Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001;88:338-356.
73. Adelstein DJ, Rice TW, Becker M, Larto MA, Kirby TJ, Koda A, Tefft M, Zuccaro G: Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997;80: 1011-1020.
74. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP: INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: highdose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-1174.
75. Urba S G, Orringer M B, Perez-Tamayo C, Bromberg J, Forastiere A: Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma. Cancer 1992;69:285-291.
76. Stahl M, Wilke H, Fink U, Stuschke M, Walz MK, Siewert JR, Molls M, Fett W, Makoski HB, Breuer N, Schmidt U, Niebel W, Sack H, Eigler FW, Seeber S: Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol 1996;14:829-837.
77. Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M: Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy. Radiology 1999;213:67-72.
78. Bartels HE, Stein HJ, Siewert JR: Tracheobronchial lesions following oesophagectomy: prevalence, predisposing factors and outcome. Br J Surg 1998;85:403-406.
79. Keller SM, Ryan LM, Coia LR, Dang P, Vaught DJ, Diggs C, Weiner LM, Benson AB: High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology Group. Cancer 1998;83: 1908-1916.
80. Swisher SG, Wynn P, Putnam JB, Mosheim MB, Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL: Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 2002; 123:175-183.
81. Urschel JD, Sellke FW: Complications of salvage esophagectomy. Med Sci Monit 2003;9: RA173-RA180.
82. Ferguson MK, Durkin AE: Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002;123:661-669.
83. Tabira Y, Okuma T, Kondo K, Yoshioka M, Mori T, Tanaka M, Nakano K, Kitamura N: Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity? Jpn J Thorac Cardiovasc Surg 1999;47:361-367.
84. Stein HJ, Brucher BL, Sendler A, Siewert JR: Esophageal cancer: patient evaluation and pretreatment staging. Surg Oncol 2001;10: 103-111.
85. Nagawa H, Kobori O, Muto T: Prediction of pulmonary complications after transthoracic oesophagectomy. Br J Surg 1994;81:860-862.
86. Nakamura T, Hayashi K, Ota M, Eguchi R, Ide H, Takasaki K, Mitsuhashi N: Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 2004;188:261-266.
87. Law SY, Fok M, Wong J: Risk analysis of squamous cell carcinoma of the esophagus. World J Surg 1994;18:339-346.